Skip to main content

BOOTHBAY FUND MANAGEMENT, LLC

Position in AVTX — Avalo Therapeutics, Inc.

CIK 1549230 NEW YORK, NY

Position in AVTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$12,973,902
+$8,132,731 QoQ
Shares Held
702,051
+116.5% QoQ
Ownership
1.31%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#31
of 125 holders
Holding Since
Sep 2021
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in AVTX Over Time

Shares Held

Position Value (USD)

Derivatives in AVTX

reported options exposure · as of Mar 31, 2026
CallValue
$1,748,303
CallShares
117,100
PutValue
$662,892
PutShares
44,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $665,103,201 across 158 Biotechnology names. AVTX ranks #8 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 AVTX
Avalo Therapeutics, Inc.
This page
702,051 $12,973,902

All Filings in AVTX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,973,902 702,051
2026-03-31 $4,841,171 324,258
2026-03-31 $662,892 44,400
2026-03-31 $1,748,303 117,100
2025-12-31 $3,670,626 202,127
2025-12-31 $310,536 17,100
2025-09-30 $2,901,654 228,297
2025-06-30 $56,491 11,321
2024-12-31 $1,218,460 163,992
2024-09-30 $1,558,874 164,092
2022-03-31 $869,098 1,198,757
2021-12-31 $2,037,886 1,198,757
2021-09-30 $2,626,747 1,204,930